CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 89 filers reported holding CTI BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $34,000 | +9.7% | 91,741 | 0.0% | 0.00% | – |
| Q2 2016 | $31,000 | -36.7% | 91,741 | 0.0% | 0.00% | – |
| Q1 2016 | $49,000 | -56.6% | 91,741 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $113,000 | +769.2% | 91,741 | +957.7% | 0.00% | – |
| Q3 2015 | $13,000 | -53.6% | 8,674 | -43.4% | 0.00% | – |
| Q1 2015 | $28,000 | +55.6% | 15,325 | +95.5% | 0.00% | – |
| Q4 2014 | $18,000 | 0.0% | 7,838 | +6.8% | 0.00% | – |
| Q3 2014 | $18,000 | -18.2% | 7,338 | -6.8% | 0.00% | – |
| Q2 2014 | $22,000 | – | 7,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $16,767,000 | 3.16% |
| Nine Chapters Capital Management LLC | 24,900 | $9,000 | 0.06% |
| FIRST NEW YORK SECURITIES LLC /NY | 53,100 | $19,875,000 | 0.01% |
| JW Asset Management, LLC | 50,254 | $19,000 | 0.01% |
| WASHINGTON TRUST Co | 410,616 | $154,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 919,200 | $344,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 37,284 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 82,880 | $31,000 | 0.00% |
| Modera Wealth Management, LLC | 25,000 | $9,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $195,000 | 0.00% |